AGX.NYSEArgan INC

Form 4: ARGAN Director Cynthia Flanders Exercises Stock Options and Vests Restricted Stock Units

Sentiment:

Insider Transaction Report


ARGAN Inc. Director Cynthia Flanders reported the exercise of multiple stock options and the vesting of restricted stock units, significantly increasing her direct beneficial ownership of common stock.

Summary

  • Cynthia Flanders, a Director of ARGAN Inc. (AGX), reported several transactions involving the company's common stock.
  • On June 9, 2025, Ms. Flanders exercised four tranches of stock options, totaling 40,000 underlying shares, using a net settle method.
  • These exercises resulted in the acquisition of 8,749 shares at an exercise price of $30.44, 7,053 shares at $71.75, 8,096 shares at $46.35, and 8,308 shares at $41.19.
  • On June 10, 2025, 390 shares of Common Stock became issuable to Ms. Flanders due to the vesting of Time-Based Restricted Stock Units (TRSUs) awarded on December 12, 2024, adjusted for dividends.
  • Following these transactions, Ms. Flanders directly beneficially owns 48,428 shares of ARGAN Inc. Common Stock.
  • She also continues to hold derivative securities, including 61,500 options at an exercise price of $30.44, 51,500 options at $71.75, 41,500 options at $46.35, 31,500 options at $41.19, and 3,417 Time-Based Restricted Stock Units.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director, especially through a net settlement, indicates a positive view on the company's stock value, as it implies the current market price is above the exercise price, making the transaction profitable. It also increases insider ownership, aligning interests with shareholders.

Positives

  • Director Cynthia Flanders exercised a significant number of stock options, indicating confidence in the company's future performance and the profitability of these awards.
  • The vesting of restricted stock units further increases the director's direct ownership, aligning her interests with those of shareholders.
  • The exercise prices ($30.44, $71.75, $46.35, $41.19) are generally lower than the implied market price at the time of exercise (given the net settlement method), suggesting a profitable transaction for the insider.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook, as its purpose is solely to report insider transactions.

Industry Context

This Form 4 filing reports routine insider equity transactions and does not provide information relevant to broader industry trends or competitive landscape analysis.

Stakeholder Impact

  • Shareholders: Increased insider ownership may be viewed positively as it aligns the director's interests with those of other shareholders.
  • Employees: The report reflects standard equity compensation practices, which can be a component of employee retention and motivation strategies.

Key Dates

DateDescription
01/07/2016Award date for stock option with exercise price $30.44.
01/05/2017Award date for stock option with exercise price $71.75.
01/11/2018Award date for stock option with exercise price $46.35.
12/12/2018Award date for stock option with exercise price $41.19.
12/12/2024Award date for Time-Based Restricted Stock Unit (TRSU).
06/09/2025Date of exercise for multiple stock options.
06/10/2025Date of vesting for Time-Based Restricted Stock Units.
06/11/2025Signature date of the reporting person for the Form 4 filing.
01/07/2026Expiration date for stock option with exercise price $30.44.
01/05/2027Expiration date for stock option with exercise price $71.75.
01/11/2028Expiration date for stock option with exercise price $46.35.
12/12/2028Expiration date for stock option with exercise price $41.19.

Recommendation

hold

Keywords

ARGAN Inc., AGX, SEC Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Transactions, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.